Literature DB >> 7782126

Evaluation of serum type III procollagen peptide as an exposure marker in retired coal workers.

R P Schins1, R J Lamers, B Préat, P J Borm.   

Abstract

Serum type III procollagen peptide (PIIIP), a degradation product of the type III collagen precursor, has been put forward as an exposure marker for mineral dust. We evaluated PIIIP levels as a marker of exposure to and effects of coal dust in retired coal miners (n = 104). To this end: (a) the individual cumulative dust exposure was calculated from job-exposure matrices, and (b) in addition to routine chest radiography (CR) of all miners according to the criteria of the International Labour Organisation (ILO), a subgroup (n = 46) was screened by high-resolution computed tomography (HRCT). Profusion score (CR and HRCT) tended to increase with cumulative dust exposure, even in the absence of CR evidence for pneumoconiosis (i.e. CR < or = 0/1, n = 35). In contrast to our previous findings in active miners, PIIIP levels were not increased in miners as compared with non-dust-exposed controls (n = 29), and no differences were observed between miners without (ILO = 0/0) and miners with coal workers' pneumoconiosis (CWP; ILO > or = 0/1). No trend in PIIIP versus pneumoconiosis stage was present, either by CR or by the more sensitive HRCT score. PIIIP was also unrelated to any lung function parameter (FEV1, FVC, impedance, diffusion capacity). Age, medication, medical history and smoking habits had no significant effect on PIIIP levels. In the miners with CWP (i.e. ILO > 0/0, n = 28) a significant negative correlation was present between PIIIP values and (log) cumulative dust exposure. This decrease in serum PIIIP levels with increasing cumulative exposure may be due to chronic adaptive changes in type III collagen deposition and/or breakdown. Other relations between exposure and PIIIP were not observed. In conclusion, the present findings do not support the use of serum type III procollagen peptide as a marker of exposure to and (early) interstitial or respiratory effects of coal dust.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7782126     DOI: 10.1007/bf00383149

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  29 in total

1.  Evaluation of serum aminoterminal propeptide of type III procollagen as an early marker of the active fibrotic process in asbestos-exposed workers.

Authors:  A Cavalleri; F Gobba; L Bacchella; D Ferrari
Journal:  Scand J Work Environ Health       Date:  1991-04       Impact factor: 5.024

2.  Quartz and pneumoconiosis in coalminers.

Authors:  A Seaton; J A Dick; J Dodgson; M Jacobsen
Journal:  Lancet       Date:  1981-12-05       Impact factor: 79.321

3.  Respiratory effects and serum type III procollagen in potato sorters exposed to diatomaceous earth.

Authors:  T H Jorna; P J Borm; K D Koiter; J J Slangen; P T Henderson; E F Wouters
Journal:  Int Arch Occup Environ Health       Date:  1994       Impact factor: 3.015

4.  High-resolution computed tomography of the lungs in coal miners with a normal chest radiograph.

Authors:  R J Lamers; R P Schins; E F Wouters; J M van Engelshoven
Journal:  Exp Lung Res       Date:  1994 Jul-Sep       Impact factor: 2.459

5.  Collagen polymorphism in idiopathic chronic pulmonary fibrosis.

Authors:  J M Seyer; E T Hutcheson; A H Kang
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

6.  Bronchoalveolar lavage in patients with mild and severe rheumatoid lung disease.

Authors:  D M Gilligan; C M O'Connor; K Ward; D Moloney; B Bresnihan; M X FitzGerald
Journal:  Thorax       Date:  1990-08       Impact factor: 9.139

7.  Protein metabolism during bleomycin-induced pulmonary fibrosis in rabbits. In vivo evidence for collagen accumulation because of increased synthesis and decreased degradation of the newly synthesized collagen.

Authors:  G J Laurent; R J McAnulty
Journal:  Am Rev Respir Dis       Date:  1983-07

8.  Airflow obstruction and monocyte TNF release in coal workers.

Authors:  T H Jorna; R P Schins; L Lenaerts; T J Derhaag; E F Wouters; P J Borm
Journal:  Exp Lung Res       Date:  1994 Jul-Sep       Impact factor: 2.459

9.  Serum procollagen III peptide levels in subjects with sarcoidosis. A 5-year follow-up study.

Authors:  W R Pohl; A B Thompson; H Köhn; S Losch; H Umek; E Legenstein; F Kummer; S I Rennard; H Klech
Journal:  Am Rev Respir Dis       Date:  1992-02

10.  Immunohistochemical study of collagen types in human foetal lung and fibrotic lung disease.

Authors:  E D Bateman; M Turner-Warwick; B C Adelmann-Grill
Journal:  Thorax       Date:  1981-09       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.